Cryptogenic Stroke
NEJM 374:2065-2074, Saver, J.L., 2016
Patent Foramen Ovale Management for Secondary Stroke Prevention:State-of-the-Art Appraisal of Current Evidence
Stroke 55:236-247, Sposato,L.A.,et al, 2024
May-Thurner Syndrome as a Cause of Embolic Stroke of Undetermined Source in a Young Patient
Neurol 92:e2507-e2509, De Leon-Benedetti, A.,et al, 2019
Patent Foramen Ovale Closure or Anticoagulation Vs. Antiplatelets after Stroke
NEJM 377:1011-1021,1006,1093, Mas, J.L,et al, 2017
Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke
NEJM 377:1033-1042,1006,1093, Sondergaard, L.,et al, 2017
Clinicopathologic Conference, Acute Ischemic Stroke, Caused by Paradoxical Embolism Through a Patent Foramen Ovale, in a Patient with the May-Thurner Syndrome and a Hypercoagulable State Due to an Occult Renal-Cell Carcinoma
NEJM 374:1671-1680, Case 13-2016, 2016
Diagnostic Yield of Pelvic Magnetic Resonance Venography in Patients with Cryptogenic Stroke and Patent Foramen Ovale
Stroke 45:2324-2329, Liberman, A.L.,et al, 2014
Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale
NEJM 366:991-999,1048, Furlan,A.J.,et al, 2012
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:227-276, Furie,K.L.,et al, 2011
May-Thurner Syndrome in Patients with Cryptogenic Stroke and Patent Foramen Ovale
Stroke 40:1502-1504, Kiernan, T.J.,et al, 2009
An Electrocardiographic Criterion for Diagnosis of Patent Foramen Ovale Associated with Ischemic Stroke
Stroke 29:1393-1397, Ay,H.,et al, 1998